Document is current
Any future updates will be listed below
-
Authors
Schramm, Zachery A.
Leroux, Brian G.
Radick, Andrea C.
Ventura, Alicia S.
Klein, Jared W.
Samet, Jeffrey H.
Saxon, Andrew J.
Kim, Theresa W.
Tsui, Judith I. https://orcid.org/0000-0003-0877-5399
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03779997 at ClinicalTrials.govDocuments that mention this clinical trial
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial
https://doi.org/10.1186/s13722-020-00203-9
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R44DA044053)
- License Information
-
More Information
Article History
Received: 14 February 2020
Accepted: 21 July 2020
First Online: 31 July 2020
Ethics approval and consent to participate
: The TAAB study received approval from the University of Washington’s Institutional Review Board (IRB) in Seattle, Washington (IRB00005069) and from Boston University School of Medicine Institutional Review Board in Boston, Massachusetts (H-37779). The study follows adverse events reporting procedures required by the National Institute on Drug Abuse (NIDA) and each institution’s IRB. This study is registered at ClinicalTrials.gov (NCT03779997).
: Not applicable.
: Andrew Saxon receives compensation as an advisor to Alkermes, Inc. and also receives travel support from Alkermes, Inc. The remaining authors declare that they have no competing interests. Specifically, none of the authors are employees of emocha Mobile Health, Inc. nor received in-kind donations or funding that was not through NIDA.
